Strategic Advisory Group Biographies

The Strategic Advisory Group is made up of recognized experts and leaders from government, education and industry, and serves as a resource for identifying new and emerging innovation trends in technology, as well as for reviewing the results of the Institute's research efforts.

 

Peter Arzberger, Ph.D.

Director, NBCR Life Sciences Initiatives

Dr. Peter Arzberger is the Chair of the Pacific Rim Applications and Grid Middleware Assembly (PRAGMA) Steering Committee and co-investigators with Philip Papadopoulos and Mason Katz on the NSF award that funds some of the US participation in PRAGMA. One of his motivations to help found PRAGMA was to bring together researchers from different disciplines to focus on scientific applications using the newest grid and information technologies. Working with others, new activities have been built off of the PRAGMA framework, in particular the Pacific Rim Undergraduate Research Experiences, providing undergraduate students the opportunity to conduct research at one of four PRAGMA partner sites and the Lake Metabolism project and the Global Lake Ecological Observatory Network (GLEON), a international, grassroots effort involving people, data, and instruments, to better understand lake dynamics.

Dr. Arzberger leads the National Biomedical Computation Resources, an NIH Research Resource, that typifies the merging of computing and information technologies to catalyze and facilitate biomedical research across a broad range of biological scales. He is also the Director of the Life Sciences Initiative at the University of California, San Diego. In this role he works with cognizant faculty and all units on campus to coordinate initiatives on campus and in the community to advance the goals of UCSD in the era of genome-enabled science. This involves working across the interface of biomedical research and computing and information technologies.

He is the former Executive Director of the San Diego Supercomputer Center and the NSF-funded National Partnership for Advanced Computing. He also worked at the National Science Foundation as program director of the Computational Biology Program in BIO and program director of the Statistics and Probability program in the Directorate for Mathematics and Physical Sciences, and as Deputy NSF High Performance Computing and Communications (HPCC) Coordinator. He has a Ph.D. in mathematics from Purdue University, in a topic that interfaced mathematics, computing, and population biology. His hobbies include working on Lloyds and collecting masks from around the world.

 

Michael T. Brown, Ph.D.

Business Development Manager, GE Global Research

After working in the Semiconductor, Heating Ventilation and Air Conditioning, and Aerospace industries, Mr. Brown joined General Electric in 2000 as a business development manager at their Global Research facility located in Niskayuna, NY. In this role Mr. Brown led the overall external collaboration research and development efforts for Healthcare, Inspection Technologies and Bioinstrumentation.

As a Business Development Manager, Mr. Brown has helped to foster successful win-win research collaborations and partnerships between state and federal governments including the National Institutes of Health, the Department of Defense (DARPA, US Army, US Navy), many of the leading academic institutions, and pharmaceutical companies to increase the rate of innovation and technology.

Mr. Brown has been trained in GE’s Six Sigma processes and has played a key role in developing GE’s Design for Six Sigma (DFSS) for marketing program. DFSS for marketing is a structured, data-driven approach for assessing market needs and opportunities and developing business cases for potential programs. Mr. Brown has used these tools to identify market needs, down select projects, develop business cases, and determine external-collaboration strategies for several areas.

Most recently, Mr. Brown has taken a position with General Electric Healthcare as an Enterprise General Manager.

He has an electrical engineering degree from Northeastern University in Boston, MA, and a Master of Business Administration with a concentration in Marketing from Rensselaer Polytechnic Institute, in Troy, NY.

 

William Y. Chang, Ph.D.

Director, National Science Foundation Beijing Office

In February 2005, Dr. William Y. B. Chang was appointed the first Director of the National Science Foundation’s Office in Beijing, China and S&T Attache at the U.S. Embassy in Beijing. The purpose of this office is to facilitate and strengthen collaboration between American and Chinese scientists and engineers which further U.S. science and technology interests.

Dr. Chang has over 20 years experience with China—in the areas of science and engineering research, education, program management, and policy. Prior to heading NSF’s Beijing Office, Dr. Chang was the Program Director responsible for the Foundation’s cooperative programs with China, Taiwan, Mongolia and Southeast Asia, in the Office of International Science and Engineering (OISE). Chang joined the Foundation in 1988 as China Program Manager in the Division of International Programs.

Before coming to NSF, he was a faculty member in aquatic ecology at the University of Michigan between 1979 and 1988. He received his M.A. (1975) and Ph.D. (1978) in biology from Indiana University, with a minor in mathematics and statistics. He earned his M.S. in marine science from the University of the Pacific in 1973. From 1990-1993, in addition to his NSF position, he served as a Distinguished Visiting Scientist at the EPA’s Environmental Research Laboratory at Corvallis, Oregon, leading an international research effort on the impact of monsoons on large lake ecosystems.

Dr. Chang began his involvement in research and education with China in 1982 as a faculty member of the University of Michigan, when he was selected by the U.S. National Academy of Sciences to spend nine months in China conducting collaborative research there. Since then, he has been deeply involved in U.S.-China research programs, education and training exchanges, and policy. He has served as science advisor to many Chinese research institutes and national committees, and as Senior Technical Adviser to United Nations Development Program.

He is the author of more than eighty publications in the areas of ecology, environmental science, and water resources; many of them focused on China. He has edited three books, and serves on the advisory and editorial boards of five learned societies.

 

Conrad A. Clyburn, M.S.

Associate Director for Emerging Technology, ISIS Center, Georgetown University

From 1997 to 2005, Mr. Clyburn served as Director of Program Integration and Planning for the U.S. Army Medical Research and Material Command, Telemedicine and Advanced Technology Research Center (TATRC) in Fort Detrick, Maryland. In that capacity, Mr. Clyburn was responsible for life cycle management of more than 500 medical research and development programs, managing a budget of approximately $300 million. His responsibilities included execution of academic, government and industry programs in telemedicine, medical informatics, advanced surgical technology and imaging, bioinformatics, medical modeling and simulation, as well as biosurveillance, robotics, biomaterials, tissue engineering and nanotechnology. During his tenure, TATRC-funded programs spearheaded the development of numerous medical technologies that are now being used by U.S. troops and other federal agencies. These programs have generated hundreds of peer reviewed medical articles, invention disclosures, patent filings, and dozens of licenses that have spawned several early stage businesses.

 

Henry Etzkowitz Ph.D.

Chair & Professor of Management Innovation, Creativity and Enterprise, University of Newcastle

Dr. Etzkowitz is Visiting Research Professor in the Department of Technology and Society, School of Engineering and Applied Sciences, Stony Brook University. He served for many years as Director of the Science Policy Institute, SUNY Purchase. In 2006, he takes up the chair in Management of Innovation, Creativity and Enterprise at the Business School, University of Newcastle-Upon-Tyne U.K. where he will serve as co-Director of the KITE (Knowledge, Innovation, Technology, Enterprise Research Centre.)

Dr. Etzkowitz is author of Triple Helix: A New Model of Innovation (Stockhom: SNS and Beijing: Peoples Press, 2005., MIT and the Rise of Entrepreneurial Science (London: Routledge, 2002). He is also co-author of Public Venture Capital (New York: Harcourt, 2000) and Athena Unbound: The Advancement of Women in Science and Technology (Cambridge: Cambridge University Press, 2000). He regularly publishes in Research Policy, Science and Public Policy, Minerva and the Journal of Technology Transfer.

He is co-founder of the Triple Helix international conference series on university-industry-government relations. (Amsterdam, 1996; New York, 1998; Rio de Janeiro, 2000; Copenhagen, 2002; Torino, 2005. Singapore 2007) www.triplehelix6.com. His honors include Founding Chair of the Section on Science, Knowledge and Technology in the American Sociological Association. He has been awarded numerous research grants from the National Science Foundation and other foundations. He is a consultant to the Center for Business and Policy Studies (SNS) Stockholm, Sweden and the SUNY Research Foundation on technology transfer.

 

David Finegold, Ph.D.

Dean, School of Management and Labor Relations, Rutgers University

David Finegold is the Dean of the School of Management and Labor Relations at Rutgers, the State University of New Jersey. Prior to joining Rutgers, Dr. Finegold was a professor at the Keck Graduate Institute in Claremont, CA and at USCÂ’s Marshall School of Business. He is the author of more than 90 articles, book chapters and policy reports, and has written or edited six books, including Corporate Boards: Adding Value at the Top (with Jay Conger and Ed Lawler) and BioIndustry Ethics (Elsevier Academic Press, 2005). He consults and provides executive education and coaching to public and private sector organizations on issues about talent management and employee development, corporate governance, integrating ethics into strategic decision-making, and designing effective organizations.

 

Michael E. Fitzgerald

President and Chief Executive Officer, NextTechs Technologies LLC

Mr. Fitzgerald is the founder of NextTechs Technologies LLC, www.nexttechs.com, a global technology Investment Bank that focuses solely on corporate technology intermediation. NextTechs maintains direct relationships with 300 + corporations and indirect relationships with another 5,700 companies worldwide. NextTechs clients represent 41 industries that utilize 141 technology research domains.

Mike’s functional specialties are finance and emerging technologies. During his 20+ years in financial services, he has served as Senior Vice President at Chase Manhattan and Chemical Banks, Managing Director of Continental Bank, and Vice President of Citicorp Investment Bank. All of this time was spent in capital markets and structured finance. In industry, he has worked as Vice President of Business Development at American Electric Power Energy Services, where he focused on alternative energy sources, and as Domestic and International Treasurer for Motorola, Inc., where he financed global operations.

Mike holds a BS in Accounting from the University of Illinois, an MBA in Finance and International Business from DePaul University and is a CPA. He is President of KRN Advisors, a private equity consulting firm, and Co-founder, President and CEO of Technology Tree Group, Inc., a private equity firm that holds a nationwide Space Act Agreement with NASA for commercialization of agency technologies. Mike has been an Adjunct Professor at the University of Houston Center for Entrepreneurship and Innovation.

 

David J. Galas, M.D., Ph.D.

Vice President and Chief Scientific Officer, Battelle Memorial Institute

Dr. Galas, Ph.D. is Professor at the Institute for Systems Biology and Vice President and Chief Scientific Officer of the Battelle Memorial Institute, an international non-profit science and technology organization. He was previously Chancellor, Chief Scientific Officer and Norris Professor of Applied Life Science at the Keck Graduate Institute of Applied Life Sciences (KGI), in Claremont CA. Before founding and developing KGI, a new research and educational institution in the applied life sciences, Dr. Galas served as President and Chief Scientific Officer of Seattle-based Chiroscience R&D Inc., a genomics and drug discovery company. This company was formed through the acquisition of Darwin Molecular Corporation, which he co-founded in 1993. Prior to his involvement in the biotechnology industry, he served as Director for Health and Environmental Research at the U.S. Department of Energy's Office of Science, where he headed the DOE's Human Genome Project from 1990 to 1993, on leave from the University of Southern California, where was Professor of Molecular Biology for twelve years, and directed the Molecular Biology section of the Biological Science Department.

Dr. Galas' formal educational training was not in molecular biology, but in physics. He received his Ph.D. in physics from the University of California, Davis-Livermore, and his undergraduate degree in physics from the University of California, Berkeley. He has also held research positions at the University of Geneva, Switzerland, and the University of California's Lawrence Livermore Laboratory. His broad research interests include areas of molecular biology and human genetics, the development and application of new technologies in the life sciences, and the understanding of complex biological networks. He is the recipient of several awards including the Smithsonian Institution-Computer World Pioneer award in 1999. He has served on many federal, university and corporate boards and advisory committees, including the National Research Council Board on Life Science, the Board of Directors of the Hertz Foundation, and the National Cancer Policy Board. He is a lifetime National Associate of the National Academy of Sciences.

 

Warren S. Grundfest, M.D.

FACS Professor of Bioengineering, Electrical Engineering, and Surgery, University of California, Los Angeles

Dr. Grundfest received his M.D. from Columbia University and his surgical training at UCLA Medical Center and Cedars-Sinai Medical Center. He joined the Cedar Sinai staff in 1985 and was appointed Director of Surgical Research in 1987.

Following his tenure at Cedars-Sinai, Dr. Grundfest served as a Visiting Associate in Mechanical Engineering at the California Institute of Technology working on surgical robotics. In 1999 he became the Founding Chair of the Bioengineering Program at UCLA, which he helped build into a department.

He currently serves as a Professor of Bioengineering, Electrical Engineering, and Surgery at UCLA.

From 1999 to 2003, Dr. Grundfest served as a Member of the Surgery and Bioengineering Study Section of the Center for Scientific Review of the National Institutes of Health. He continues to participate in several different NIH Study Sections, reviewing imaging technologies, cardiovascular devices, and cancer detection methods.

 

Bernard A. Harris, Jr., M.D.

President and Chief Executive Officer, Vesalius, Inc.

Dr. Harris is an accomplished astronaut, physician and businessman. He is the first African-American to walk in space. Selected by NASA in 1990, Dr. Harris was a Mission Specialist on the Space Shuttle Columbia STS-55/Spacelab D-2 in 1993. As Payload Commander on Space Shuttle Discovery STS-63 in 1995, he served on the first flight of the joint Russian-American Space Program. At the time of his retirement from NASA in 1996, he had logged more than 438 hours in space and traveled over 7.2 million miles. Equally as impressive as his space career, he has developed a broad range of business talents. Currently, Dr. Harris is president and founder of The Harris Foundation, which supports math/science education and crime prevention programs for America’s youth and president and CEO of Vesalius Ventures, a unique venture capital vehicle solely dedicated to funding the development of new technologies in order to advance the world of telemedicine.

Dr. Harris holds a bachelor of science in Biology from the University of Houston, a master of medical science from the University of Texas Medical Branch at Galveston, an MBA from the University of Houston and a doctorate of medicine from Texas Tech University School of Medicine. He completed a residency in Internal Medicine at the Mayo Clinic, a National Research Council Fellowship in Endocrinology at the NASA Ames Research Center and trained as a Flight Surgeon at the Aerospace School of Medicine, Brooks Air Force Base. Throughout his career, he has received numerous awards and recognition, including the election as Fellow of the American College of Physicians and is a recipient of the Horatio Alger Award.

 

Dave D. Hood, MS, MBA, PMP

President, DH3 & Associates

Dave D. Hood is the President of DH3 & Associates, a company that focuses on working with the US Government, industry, and academia to move new medical technology and products into commercialization. He also serves as the Senior Advisor for the Principle Assistant for Acquisition at the United States Medical Research and Material Command.

Mr. Hood worked with Rockwell International and Northrop Grumman attaining senior management positions. He successfully guided the development of various sensor systems for high performance aircraft, missiles, and satellites including the stealth bomber, stealth fighter and the Global Positioning Satellites (GPS).

Mr. Hood has worked with Congress and the financial community to raise capital focusing on non-dilutive funding. He holds 3 patents and has been the stimulus for more than 2 dozen. He published and presented in the US and Europe. He taught graduate school courses in Project Management, Business Management, Operations Management and Entrepreneurship. He is currently consulting for the US Army Surgeon General’s Medical Research and Material Command where he assists with the commercialization of promising new technologies.

 

Chris Johnson, Ph.D.

Director, Scientific Computing and Imaging Institute

Dr. Johnson founded the SCI research group in 1992 which has since grown to become the SCI Institute employing over 100 faculty, staff and students. He serves on several international journal editorial boards, as well as on advisory boards to several national research centers.

He was awarded a Young Investigator’s (FIRST) Award from the NIH in 1992, the NSF National Young Investigator (NYI) Award in 1994, and the NSF Presidential Faculty Fellow (PFF) award from President Clinton in 1995. In 1996 he received a DOE Computational Science Award and in 1997 received the Par Excellence Award from the University of Utah Alumni Association and the Presidential Teaching Scholar Award. In 1999, he was awarded the Governor’s Medal for Science and Technology from Governor Michael Leavitt. In 2003 he received the Distinguished Professor Award from the University of Utah. In 2004 he was elected a Fellow of the American Institute for Medical and Biological Engineering and in 2005 he was elected a Fellow of the American Association for the Advancement of Science. He directs the Scientific Computing and Imaging Institute.

Dr. Johnson currently directs the Scientific Computing and Imaging Institute at the University of Utah where he is a Distinguished Professor of Computer Science and holds faculty appointments in the Departments of Physics, and Bioengineering. He also co-directs The Center for Integrative Biomedical Computing (CIBC), co-founded Visual Influence Inc., and co-edited The Visualization Handbook.

His research interests are in the area of scientific computing. Particular interests include inverse and imaging problems, adaptive methods, problem solving environments, numerical analysis, biomedical computing, and scientific visualization.

 

Yongmin Kim, Ph.D.

Professor and Chair, University of Washington Department of Bioengineering

Dr. Yongmin Kim leads a department whose visionary faculty has a track record of 362 inventions, 212 patents, 75 license agreements, and 25 spin-off companies. Not surprisingly for such a prolific unit, UW Bioengineering is first nationwide in research funding from the National Institutes of Health. His personal accomplishments include 71 inventions, 69 patents, and 21 commercial licenses. Among his most prestigious awards are fellowships in the American Institute of Medical and Biological Engineering and the Institute for Electrical and Electronic Engineers. In June he was honored in Seoul, Korea as the 2003 Laureate of the Ho-Am prize in Engineering. He earned his doctorate in electrical engineering from the University of Wisconsin-Madison and concentrates his research on medical imaging and computing, distributed diagnosis, and home health care. A University of Washington faculty member since 1983, he assumed the chair of Bioengineering in 1999. He is the director of both the Image Computing Systems Laboratory at the University of Washington and several University of Washington Image Computing Library (UWICL) Consortia.

Dr. Kim’s research interests include medical imaging and computing, ultrasound systems, electronic medicine, distributed diagnosis and home healthcare, and molecular imaging. He has participated heavily in the architecture definition and optimization as well as algorithm simulation and system development for Texas Instruments TMS320C80 Multimedia Video Processor (MVP) and Hitachi/Equator Technologies Media Accelerated Processor (MAP). He edited a book, Handbook of Medical Imaging (SPIE Press, 2000) and is a contributing author to many books. He has more than 450 research publications, and he is the editor of 11 Conference Proceedings.

He was awarded the 1988 Early Career Achievement Award of the IEEE Engineering in Medicine and Biology Society for his contributions to medical imaging and the 2003 Ho-Am Prize in Engineering. In 2005, he received a Distinguished Achievement Award from the University of Wisconsin-Madison College of Engineering. He is a Fellow of the IEEE and a Fellow of the American Institute for Medical and Biological Engineering. He is a member of Tau Beta Pi and Eta Kappa Nu.

 

Mary Kratz, MT (ASCP)

Head of Academic Information Services, University of Michigan Medical School

Mary Kratz is the head of academic information services at the University of Michigan Medical School.

As Internet2’s initial Health Sciences chief, Ms. Kratz drew on her clinical and research experience as a Medical Technologist to foster advanced networking capabilities for the academic community. Her background in medical informatics continues to serve many communities of practice in the development and deployment of cyber-infrastructure nationally and internationally.

Ms. Kratz earned a Bachelor of Science in Medical Technology from Michigan State University. She completed her laboratory training at Wayne State University, received her licensures from the American College of Clinical Pathology and is a registered National Laboratory Scientist.

 

Peter Lyster, Ph.D.

Program Director, Center for Bioinformatics and Computational Biology, NIH/NIGMS

Dr. Lyster received his Ph.D. in plasma physics from Cornell University. While there on a Fulbright scholarship, he developed computational models for nuclear fusion. He continued this research as a postdoctoral fellow at the Institute for Fusion Studies at the University of Texas at Austin. Lyster then focused on computational models for analyzing earth science data. He worked for 4 years at the Jet Propulsion Laboratory at the California Institute of Technology, where he developed high performance computing algorithms to visualize geophysical data. He spent the next 7 years at the NASA Data Assimilation Office at Goddard Space Flight Center in Greenbelt. He was the principal investigator there on a grant from NASA to develop computational methods for assimilating atmospheric data into models of weather and climate change.

 

Daniel Morse, Ph.D.

Professor of Molecular Genetics and Biochemistry, UCSB-MIT-Caltech Institute for Collaborative Biotechnologies

Dr. Morse is Director of the Army’s Institute for Collaborative Biotechnologies at the University of California, Santa Barbara. He received his B.A. degree in Biochemistry from Harvard, his Ph.D. in Molecular Biology from Albert Einstein College of Medicine, and conducted postdoctoral studies in Molecular Genetics at Stanford University. He was the Silas Arnold Houghton Associate Professor of Microbiology and Molecular Genetics at Harvard Medical School before joining the faculty as Professor of Molecular Genetics and Biochemistry of the University of California. His research is focused at the interface between molecular biology, biotechnology and materials science with an emphasis on energy applications, optoelectronics and adaptive optical materials. He recently was honored by Scientific American as one of the top 50 technology innovators of 2006 for his development of bio-inspired kinetically controlled routes to semiconductor thin films and nanoparticles. He was selected the 7th Kelly Lecturer in Materials and Chemistry at the University of Cambridge and the 3M Lecturer in Chemistry and Materials at the University of Vancouver in Canada last year. Previous honors include election as a Fellow of the AAAS and the Smithsonian Institution; award of a Career Development Award from the National Institutes of Health and a Faculty Research Award from the American Cancer Society; and recognition as Visiting Professor at the University of Paris and universities in Japan, Singapore and the UK. His students have received international recognition and awards in numerous symposia and international research meetings.

 

Jonathan Rosen, Ph.D.

Executive Director, Institute of Technology Entrepreneurship & Commercialization (ITEC)

Dr. Jonathan Rosen is currently the Executive Director of the new Institute for Technology Entrepreneurship and Commercialization (ITEC) at Boston University School of Management. He continues his role at CIMIT as Senior Advisor to the Director, remaining closely involved in the ongoing development of technology implementation pathways and in documenting metrics of facilitation.

Until October 2006, Dr. Rosen directed the CIMIT Office of Technology Implementation. This office works with CIMIT investigators, licensing offices and the investor community to design and implement new models for improving patient care by partnering innovative new medical technologies with product development environments. This CIMIT resource provides support for prototyping new devices, managing intellectual property, and evaluating the potential health care impact of emerging new technologies.

 

Benjamin H. Wu, D.D.S., Ph.D.

Co-Director, Weintraub Center for Reconstructive Biotechnology

Prof. Ben Wu received his D.D.S. from the University of Pacific, his advanced prosthodontics specialty certificate at the Harvard School of Dental Medicine, and his Ph.D. in Materials Science and Engineering from the Massachusetts Institute of Technology. He is currently Associated Professor and Vice Chair of the UCLA Department of Bioengineering, with joint appointment in the Department of Materials Science and Engineering, and in the School of Dentistry at UCLA. Prof. Wu is Co-Director of the Weintraub Center for Reconstructive Biotechnology, and a member of the UCLA Brain Research Institute, the California NanoSystems Institute, and the Academy of Prosthodontics.

 

Leroy Hood, M.D., Ph.D.
President, Institute for Systems Biology
Seattle, WA

Dr. Hood’s research has focused on the study of molecular immunology, biotechnology, and genomics. His professional career began at Caltech where he and his colleagues pioneered four instruments — the DNA gene sequencer and synthesizer, and the protein synthesizer and sequencer — which comprise the technological foundation for contemporary molecular biology. In particular, the DNA sequencer has revolutionized genomics by allowing the rapid automated sequencing of DNA, which played a crucial role in contributing to the successful mapping of the human genome during the 1990s. In 1992, Dr. Hood moved to the University of Washington as founder and Chairman of the cross-disciplinary Department of Molecular Biotechnology. In 2000, he co-founded the Institute for Systems Biology in Seattle, Washington to pioneer systems approaches to biology and medicine.

Most recently, Dr. Hood’s lifelong contributions to biotechnology have earned him the prestigious 2004 Association for Molecular Pathology (AMP) Award for Excellence in Molecular Diagnostics. He was also awarded the 2003 Lemelson—MIT Prize for Innovation and Invention, the 2002 Kyoto Prize in Advanced Technology and the 1987 Lasker Prize for his studies on the mechanism of immune diversity. He has published more than 500 peer-reviewed papers, received 14 patents, and has co-authored textbooks in biochemistry, immunology, molecular biology, and genetics, and is a member of the National Academy of Sciences, the American Philosophical Society, the American Association of Arts and Sciences, and the Institute of Medicine. Dr. Hood has also played a role in founding numerous biotechnology companies, including Amgen, Applied Biosystems, Systemix, Darwin and Rosetta.